Zydus Cadila gets tentative USFDA nod to market generic sclerosis treatment drug

Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market Fingolimod capsules, used in the treatment of multiple sclerosis, in the American market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3gRvxCX
via IFTTT